Kuraray Co (KURRF) Price & Analysis

Compare

3 Followers

KURRF Stock Chart & Stats

$10.20

$0.00(0.00%)

At close: Oct 16 4:00 PM EDT

$10.20

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$9.28 - $13.90

Previous CloseN/A

Volume1.72K

Average Volume (3M)0.00

Market Cap

$3.37B

Enterprise Value$714.14B

Total Cash (Recent Filing)$115.00B

Total Debt (Recent Filing)$265.64B

Price to Earnings (P/E)67.2

Beta0.87

Next Earnings

May 20, 2026

EPS Estimate

0.11

Next Dividend Ex-DateN/A

Dividend Yield3.94%

Share Statistics

EPS (TTM)-0.30

Shares Outstanding307,963,600

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio-0.89

Price to Book (P/B)0.68

Price to Sales (P/S)0.62

P/FCF Ratio536.20

Enterprise Value/Market Cap211.72

Enterprise Value/Revenue0.88

Enterprise Value/Gross Profit2.84

Enterprise Value/Ebitda5.11

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.81

Revenue Forecast (FY)$5.37B

Bulls Say, Bears Say

Bulls Say

Diversified, High-value Product PortfolioKuraray's portfolio of differentiated polymers (PVA, EVOH) and advanced materials used across packaging, automotive, electronics and healthcare underpins durable pricing power and customer stickiness. Global manufacturing and R&D networks support long-term product development and supply reliability, reducing single-market cyclicality and enabling sustained relationships with industrial customers.

Gross Margin Resilience And Operating ProfitabilitySteady gross margins around 30–32% despite recent earnings volatility indicate the business retains underlying product-level value capture. Consistent gross margin and continued operating profitability imply the company can sustain core manufacturing economics, absorb some cost shocks, and benefit from margin recovery if volumes normalise or pricing actions and mix improvements persist.

Stable Balance Sheet With Manageable LeverageImproving and moderate debt metrics give Kuraray financial flexibility to fund capex, R&D and dividends while withstanding cyclical downturns. A growing equity base and controlled leverage reduce refinancing risk and support creditworthiness, allowing longer-term investments in specialty materials and capacity without immediate pressure to cut strategic programs.

Bears Say

Sharp Profitability CompressionThe collapse in net margin to near 1% materially reduces retained earnings and long-term return on capital. Persistent margin compression can impair the firm's ability to invest in higher-margin innovation, sustain dividends, and maintain ROE, suggesting structural pressure from cost pass-through limits, competitive pricing, or end-market weakness that may last beyond transitory cycles.

Free Cash Flow Deterioration And Weak Cash ConversionNear-zero free cash flow and worsening cash conversion constrain funding for capex, debt reduction and shareholder returns, and increase reliance on external financing for strategic initiatives. Inconsistent free cash flow history points to working-capital volatility and reduces the margin for operational setbacks, making multi-year investment planning and balance-sheet improvement harder.

Top-line Weakness In 2025A reversal from prior expansion to slight revenue decline signals weakening demand or loss of volumes in key end markets. Reduced top-line growth undermines operating leverage and makes margin and cash recovery harder, indicating potential structural softness in end-market exposure (packaging, auto, electronics) or competitive/share pressures that could persist over several quarters.

Kuraray Co News

Calgon Carbon invests $100M for drinking water carbon reactivation capacity

Calgon Carbon Corporation announced a major expansion of drinking water carbon reactivation capacity at its Columbus, Ohio, plant....

9d ago

Kuraray Advances ¥10 Billion Share Buyback, Acquires 1.75 Million Shares

Kuraray Co ( ($JP:3405) ) has issued an update. Kuraray Co., Ltd. has been executing a share buyback...

4d ago

Kuraray Keeps Annual Dividend Steady at ¥54 Per Share for Fiscal 2025

Kuraray Co ( ($JP:3405) ) has shared an announcement. Kuraray Co., Ltd. has proposed a year-end dividend of...

18d ago

Kuraray Profit Slumps on Inventory Effects and Isoprene Impairment in FY2025

The latest announcement is out from Kuraray Co ( ($JP:3405) ). Kuraray reported fiscal 2025 net sales of...

25d ago

Kuraray Marks 100th Anniversary With Higher Commemorative Dividend

Kuraray Co ( ($JP:3405) ) has issued an update. Kuraray Co., Ltd., a Japanese specialty chemicals and advanced...

25d ago

Kuraray Launches ¥10 Billion Share Buyback to Boost Capital Efficiency

Kuraray Co ( ($JP:3405) ) has provided an update. Kuraray Co., Ltd. is a Japanese chemical manufacturer specializing...

25d ago

Kuraray Takes ¥25.6 Billion Impairment as Profit Undershoots Forecast but Keeps Dividend

An announcement from Kuraray Co ( ($JP:3405) ) is now available. Kuraray said it booked a ¥25.6 billion...

25d ago

Kuraray Profit Plunges on Weaker Margins Despite Modest Sales Decline in 2025

The latest update is out from Kuraray Co ( ($JP:3405) ). Kuraray reported consolidated net sales of ¥808.4...

25d ago

Is KURRF a Buy, Before Earnings?

Kuraray Co (KURRF) is scheduled to report 4th quarter earnings on 02/10/2026, before the market opens. Regarding Q4...

27d ago

Kuraray downgraded to Sell from Buy at Goldman Sachs

Goldman Sachs double downgraded Kuraray (KURRY) to Sell from Buy with a price target of 1,540 yen, down...

4M ago

Kuraray Co. Reports Decline in Nine-Month Earnings

Kuraray Co ( ($KURRF) ) has released its Q3 earnings. Here is a breakdown of the information Kuraray...

4M ago

Kuraray Co. to Cancel 16.9 Million Treasury Shares

Kuraray Co ( ($JP:3405) ) has shared an update. Kuraray Co., Ltd. has announced the cancellation of 16,900,000...

4M ago

Kuraray upgraded to Buy from Neutral at Goldman Sachs

Goldman Sachs analyst Atsushi Ikeda upgraded Kuraray to Buy from Neutral with an 1,880 yen price target. The...

3y ago

Kuraray upgraded to Neutral from Sell at Goldman Sachs

Goldman Sachs analyst Atsushi Ikeda upgraded Kuraray to Neutral from Sell with a price target of 1,440 yen,...

3y ago

KURRF FAQ

What was Kuraray Co Ltd’s price range in the past 12 months?

Kuraray Co Ltd lowest stock price was $9.28 and its highest was $13.90 in the past 12 months.

What is Kuraray Co Ltd’s market cap?

Kuraray Co Ltd’s market cap is $3.37B.

When is Kuraray Co Ltd’s upcoming earnings report date?

Kuraray Co Ltd’s upcoming earnings report date is May 20, 2026 which is in 74 days.

How were Kuraray Co Ltd’s earnings last quarter?

Kuraray Co Ltd released its earnings results on Feb 10, 2026. The company reported -$0.302 earnings per share for the quarter, missing the consensus estimate of $0.044 by -$0.347.

Is Kuraray Co Ltd overvalued?

According to Wall Street analysts Kuraray Co Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Kuraray Co Ltd pay dividends?

Kuraray Co Ltd pays a Semiannually dividend of $0.172 which represents an annual dividend yield of 3.94%. See more information on Kuraray Co Ltd dividends here

What is Kuraray Co Ltd’s EPS estimate?

Kuraray Co Ltd’s EPS estimate is 0.11.

How many shares outstanding does Kuraray Co Ltd have?

Kuraray Co Ltd has 307,963,600 shares outstanding.

What happened to Kuraray Co Ltd’s price movement after its last earnings report?

Kuraray Co Ltd reported an EPS of -$0.302 in its last earnings report, missing expectations of $0.044. Following the earnings report the stock price went up 0.439%.

Which hedge fund is a major shareholder of Kuraray Co Ltd?

Currently, no hedge funds are holding shares in KURRF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Kuraray Co Ltd

Kuraray Co., Ltd. engages in the production and sale of resins, chemicals, fibers, activated carbon, and high-performance membranes and systems worldwide. The Vinyl Acetate segment manufactures and markets functional resins and films, including PVA, PVB and EVAL. The Isoprene segment engages in the manufacture and marketing of SEPTON thermoplastic elastomer, isoprene-related products, and GENESTAR. The Functional Materials segment manufactures and markets methacrylic resin, medical products, and carbon materials. The Fibers and Textiles segment manufactures and sells synthetic fibers and textiles, CLARINO manmade leather, non-woven fabrics, and other products. The Trading segment mainly processes and sells synthetic fibers and manmade leathers. The company was founded in 1926 and is headquartered in Tokyo, Japan.